<strong>Chest</strong> & <strong>Heart</strong> Journal Vol. <strong>35</strong>, <strong>No</strong>.-2, July <strong>2011</strong>IntroductionIn many areas <strong>of</strong> the world tuberculosis remainsthe most common causes <strong>of</strong> pleural effusion withgranulomatous pleuritis in the absence <strong>of</strong>demonstrable pulmonary diseases 1 . About 95%cases <strong>of</strong> granulomatous pleuritis are due toinfection by M. tuberculosis 2 . Tuberculosis is anancient human disease. Today pulmonarytuberculosis has become the most importantcommunicable disease in the world which isresponsible for more morbidity <strong>and</strong> mortality thanany other bacterial infections. Around one-third<strong>of</strong> the world’s population has latent tuberculosis<strong>and</strong> that between 2002 <strong>and</strong> 2020, an estimate <strong>of</strong>1000 million people will become newly infected,150 million people will contact disease <strong>and</strong> 36million will die 3 . Bangladesh ranks 6 th thth in theworld <strong>of</strong> tuberculosis disease burden with anestimated over 3,00,000 new cases each year <strong>of</strong>whom 70,000 die per year 4 .<strong>The</strong>re is no prevalence study on granulomatouspleuritis in Bangladesh till now. A study in a smallscale was done in 2002, where prevalence <strong>of</strong> EPTBwas only 4.8% 5 . Incidence <strong>and</strong> prevalence <strong>of</strong>pulmonary TB in Bangladesh are 225/100000population per year <strong>and</strong> 391/100000 population peryear respectively 6 .Though pulmonary TB is the most commonpresentation <strong>of</strong> M. tuberculosis infection, extrapulmonary TB also constitute a frequent problem,particularly due to advancing immunosuppressionin the era <strong>of</strong> HIV infection 7,8 . Tuberculous pleuraleffusion (TPE) which usually causes grnulomatouspleuritis is the second most common form <strong>of</strong> extrapulmonary tuberculosis. Granulomatous pleuritisresults from a hypersensitivity reaction totuberculin protein 9 . <strong>The</strong> incidence <strong>of</strong>granulomatous pleuritis is linked to the localprevalence <strong>of</strong> TB in general. In India EPTBconstitutes about 15-20% <strong>of</strong> all cases <strong>of</strong> tuberculosisin immunocompitent adult, among themtuberculous pleural effusion occurs in 20% cases7 . In many areas <strong>of</strong> the world tuberculosis remainsthe most common causes <strong>of</strong> pleural effusion withgranulomatous pleuritis in the absence <strong>of</strong>demonstrable pulmonary diseases 1 . It has been amajor health problem in the developing countrylike Bangladesh.A wide range <strong>of</strong> diseases may be the cause <strong>of</strong> anaccumulation <strong>of</strong> fluid in the pleural space butgranulomatous pleuritis is almost always causedby infection with M. tuberculosis leading to pleuraleffusion 10 . Pleural effusion is a major diagnosticproblem, time may be wasted before an accuratediagnosis is made in patients with pleural effusion,as the pleura is an inner cavity with no directaccess, adding some difficulty to the diagnosis 11 .Pleural effusion can occur as a complication <strong>of</strong>many different diseases. It is a common clinicalproblem <strong>and</strong> it has been estimated that there are>800,000 cases/year in the USA. <strong>The</strong> diagnosis <strong>of</strong>granulomatous pleuritis remains a controversialissue in terms <strong>of</strong> cost to both patients <strong>and</strong> thehealthcare system. Conventional methods are notalways capable <strong>of</strong> establishing the cause <strong>of</strong> pleuraleffusion, <strong>and</strong> alternative tests permitting rapid <strong>and</strong>accurate diagnosis are greatly needed. Malignantdisease involving the pleura <strong>and</strong> parapneumoniceffusion are the leading causes <strong>of</strong> exudative pleuraleffusions 12 . Fluid collection within the pleuralcavity can be assessed with clinical <strong>and</strong> radiologicalmeans. When pleural effusion is detected, thecharacteristics <strong>of</strong> the fluid (exudate or transudate)must be revealed using thoracocentesis 13 .<strong>The</strong> determination <strong>of</strong> the aetiology <strong>of</strong> the pleuraleffusion with granulomatous pleuritis was basedon the clinical presentation, appropriate diagnostictest results <strong>and</strong> response to treatment <strong>of</strong> eachpatient 12 . Granulomatous pleuritis is thought tobe the result <strong>of</strong> a delayed hypersensitivity reactionin response to the presence <strong>of</strong> mycobacterialantigens in the pleural tissue. This immunologicreaction causes the stimulation <strong>and</strong> differentiation<strong>of</strong> lymphocyte which release lymphokines whichin turn activate macrophages for an enhancedbactericidal effect 14 . Despite the introduction <strong>and</strong>popularity <strong>of</strong> the new methods <strong>of</strong> Mycobacteriumtuberculosis detection <strong>and</strong> identification, thediagnosis <strong>of</strong> some cases <strong>of</strong> tuberculosis, continuesto pose considerable difficulty. <strong>The</strong> definitivediagnosis <strong>of</strong> granulomatous pleuritis is difficultbecause <strong>of</strong> the low sensitivity <strong>and</strong> specificity <strong>of</strong> noninvasive traditional diagnostic tools, the result <strong>of</strong>pleural fluid staining for acid fast bacilli (AFB) isvirtually negative <strong>and</strong> pleural fluid culture for AFBis positive in only
Assessment <strong>of</strong> Diagnostic Value <strong>of</strong> C-Reactive Protein<strong>The</strong> determination <strong>of</strong> biological marker levels inpleural effusions has been proposed as analternative noninvasive means <strong>of</strong> establishing adiagnosis <strong>of</strong> pleural effusion 12 . A variety <strong>of</strong>biological markers have been proposed to facilitatediagnosis <strong>of</strong> granulomatous pleuritis, includingpleural fluid concentrations <strong>of</strong> adenosinedeaminase (ADA), interferon (IFN)-ã, a variety <strong>of</strong>tumour markers <strong>and</strong> cytokines. Although there isa large body <strong>of</strong> literature on these biologicalmarkers <strong>and</strong> their utility in the diagnosis <strong>of</strong> pleuraleffusion, to date diagnosis is usually based on eachindividual marker separately 12,16,17 . But thesetests need specific <strong>and</strong>/or expensive equipment thatis not available in most laboratories. So alternativetests permitting rapid <strong>and</strong> accurate diagnosis isgreatly needed for diagnosis <strong>of</strong> granulomatouspleuritis. Measurement <strong>of</strong> C - reactive protein(CRP) level in pleural fluid is such an inexpensive,rapid <strong>and</strong> accurate diagnostic tool. CRP is an acutephase protein widely used as a marker <strong>of</strong>inflammation <strong>and</strong> tissue damage. Its determinationis simple, quick, <strong>and</strong> inexpensive. CRP has beenfound higher in granulomatous pleuritis <strong>and</strong>pneumonic pleural effusion. Several report suggestthat in patient with lymphocytic pleural effusionan elevated pleural fluid CRP level <strong>of</strong> e”50 mg/Lpredicts granulomatous pleuritis with sensitivity<strong>of</strong> 45% (CI= 23-68),<strong>and</strong> specificity <strong>of</strong> 95% (CI=89-98), LR+ 9.3 (CI=3.71-23.30), LR- 0.57 (CI=0.38-0.86)18 . On the contrary CRP <strong>of</strong>
- Page 3 and 4: THE CHEST & HEART ASSOCIATION OF BA
- Page 5 and 6: Chest & Heart JournalVol. 35, No. 2
- Page 7 and 8: Instruction to Authors About Unifor
- Page 9: Chest & Heart JournalVol. 35, No. 2
- Page 13 and 14: Assessment of Diagnostic Value of C
- Page 16 and 17: Chest & Heart Journal Vol. 35, No.-
- Page 18 and 19: Chest & Heart JournalVol. 35, No. 2
- Page 20 and 21: Chest & Heart Journal Vol. 35, No.-
- Page 22 and 23: Chest & Heart Journal Vol. 35, No.-
- Page 24 and 25: Chest & Heart Journal Vol. 35, No.-
- Page 26 and 27: Chest & Heart Journal Vol. 35, No.-
- Page 28 and 29: Chest & Heart Journal Vol. 35, No.-
- Page 30 and 31: Chest & Heart Journal Vol. 35, No.-
- Page 32 and 33: Chest & Heart Journal Vol. 35, No.-
- Page 34 and 35: Chest & Heart Journal Vol. 35, No.-
- Page 36 and 37: Chest & Heart Journal Vol. 35, No.-
- Page 38 and 39: Chest & Heart Journal Vol. 35, No.-
- Page 40 and 41: Chest & Heart Journal Vol. 35, No.-
- Page 42 and 43: Chest & Heart Journal Vol. 35, No.-
- Page 44 and 45: Chest & Heart Journal Vol. 35, No.-
- Page 46 and 47: Chest & Heart Journal Vol. 35, No.-
- Page 48 and 49: Chest & Heart Journal Vol. 35, No.-
- Page 50 and 51: Chest & Heart Journal Vol. 35, No.-
- Page 52 and 53: Chest & Heart JournalVol. 35, No. 2
- Page 54 and 55: Chest & Heart Journal Vol. 35, No.-
- Page 56 and 57: Chest & Heart Journal Vol. 35, No.-
- Page 58 and 59: Chest & Heart Journal Vol. 35, No.-
- Page 60 and 61:
Chest & Heart Journal Vol. 35, No.-
- Page 62 and 63:
Chest & Heart Journal Vol. 35, No.-
- Page 64 and 65:
Chest & Heart JournalVol. 35, No. 2
- Page 66 and 67:
Chest & Heart Journal Vol. 35, No.-
- Page 68 and 69:
Chest & Heart Journal Vol. 35, No.-
- Page 70 and 71:
Chest & Heart Journal Vol. 35, No.-